Nous
PrivateLast Round
Seed
Jul 15, 2026
Total Funding Raised
$2.65M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Nous operates in Healthcare & Life Sciences and is based in Cantù. Its latest recorded funding round was a Seed round in July 2026.
Nous is a food technology company that develops functional botanical ingredients for the food, beverage, and nutraceutical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nous Comparables
Compare Nous with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nektium Pharma | 79% | |
| Saanroo | 77% | |
| Everwell Health | 73% |
For institutional investors. Book with your work email.
Nous Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nous Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eatable Adventures | Seed |
| FoodSeed | Seed |
| CDP Venture Capital SGR | Seed |
| DSM-Firmenich Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased from 0 to 2, representing 22% of headcount.
- Aug 22, 2026
Monthly visitors grew 397% MoM, from 604 to 3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesAug 11, 2026
Nous partners with dsm-firmenich to launch Koncentra, a botanical functional ingredient for energy, focus and mood support, as the companies accelerate its global commercialization in Aug '26.
For institutional investors. Book with your work email.
Nous Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nous's valuation, stock price, and market status.
Is Nous a public or private company?
Nous is a private company.
What is the current stock price of Nous?
Nous is a private company, so its shares have no public market price. Caplight tracks Nous's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nous worth (valuation)?
Valuation information for Nous is not publicly available.
Can I buy Nous stock?
Nous shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nous's last funding round?
Nous's most recent funding round was Seed on July 15, 2026.
Who are the main investors in Nous?
Key investors in Nous include DSM-Firmenich Ventures.
Will Nous IPO soon?
No public IPO plans have been announced for Nous.
How can I track Nous secondary market activity?
Caplight tracks bids, offers, and trades in Nous's shares on secondary markets.